V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013887 | 270014426 | 1.8 | 57.4 | Palliative (P) | 2016-08-20 | 2016-09-20 | Capecitabine 35days + RT | null | N | 270015974 | CAPECITABINE + RT |
| 270013888 | 270009467 | 1.8 | 68.4 | Adjuvant (A) | 2015-07-19 | 2015-08-09 | null | N | N | 270015974 | NOT MATCHED |
| 270013889 | 270014428 | 1.73 | 106.5 | Disease modification (D) | 2015-08-28 | 2015-09-02 | null | N | null | 270015983 | NOT MATCHED |
| 270013890 | 270009471 | 1.78 | 99 | Palliative (P) | 2013-12-08 | 2013-12-21 | DHAP | N | N | 270015983 | DHAP |
| 270013891 | 270009472 | null | null | Curative (C) | 2015-11-24 | 2016-06-17 | DHAP | 02 | N | 270015986 | DHAP |
| 270013892 | 270009473 | 1.71 | 98 | Adjuvant (A) | 2013-09-02 | 2013-09-06 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270015987 | FLUOROURACIL |
| 270013893 | 270009473 | 1.75 | 85 | Curative (C) | 2014-10-16 | 2014-11-01 | CHOP R - 21 days | 02 | null | 270015987 | CHOP R |
| 270013894 | 270009474 | null | null | Neo-adjuvant (N) | 2016-03-13 | 2016-04-01 | Bevacizumab + Oxaliplatin +MdG | null | null | 270015990 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013895 | 270009475 | 1.62 | 85 | Neo-adjuvant (N) | 2015-04-07 | 2015-04-13 | Capecitabine 35days + RT | 02 | Y | 270015990 | CAPECITABINE + RT |
| 270013896 | 270009476 | 1.71 | 71.2 | Curative (C) | 2017-08-20 | 2017-08-25 | null | N | N | 270015993 | NOT MATCHED |
| 270013897 | 270009477 | 1.62 | null | Palliative (P) | 2015-12-18 | 2015-12-25 | CAPECITABINE + IRINOTECAN | N | N | 270015996 | CAPECITABINE + IRINOTECAN |
| 270013898 | 270009478 | 1.6 | 79 | Neo-adjuvant (N) | 2019-03-22 | 2019-03-31 | Capecitabine 35days + RT | 02 | null | 270016002 | CAPECITABINE + RT |
| 270013899 | 270009478 | null | null | Adjuvant (A) | 2014-03-14 | 2014-03-28 | CHOP R - 21 days | 02 | N | 270016002 | CHOP R |
| 270013900 | 270019218 | 1.61 | 66 | Curative (C) | null | 2016-08-26 | null | null | null | 270016004 | NOT MATCHED |
| 270013901 | 270019218 | 1.69 | 68 | Curative (C) | 2017-11-20 | 2017-11-27 | Trifluridine + Tipiracil | N | Y | 270016004 | TRIFLURIDINE + TIPIRACIL |
| 270013902 | 270009479 | 1.65 | 88 | Curative (C) | null | 2014-12-10 | Capecitabine (21 day) + Irinotecan | 02 | N | 270016007 | CAPECITABINE + IRINOTECAN |
| 270013903 | 270009479 | 1.76 | 82 | Palliative (P) | 2015-12-22 | 2016-01-18 | CAPECITABINE + IRINOTECAN | N | N | 270016007 | CAPECITABINE + IRINOTECAN |
| 270013904 | 270009481 | 1.7 | 70 | Palliative (P) | 2016-04-23 | 2016-04-23 | Trifluridine + Tipiracil | 02 | N | 270016013 | TRIFLURIDINE + TIPIRACIL |
| 270013905 | 270009483 | null | 52 | Curative (C) | 2016-12-09 | 2016-12-13 | CHOP R - 21 days | N | N | 270016016 | CHOP R |
| 270013906 | 270009483 | null | 84.6 | Curative (C) | 2013-07-27 | 2013-10-11 | CHOP R - 21 days | null | null | 270016016 | CHOP R |
| 270013907 | 270014438 | null | null | Curative (C) | 2018-01-29 | 2018-04-20 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270016024 | NOT MATCHED |
| 270013908 | 270014438 | 1.62 | null | Adjuvant (A) | 2013-09-04 | 2013-09-04 | Cetuximab + Radiotherapy Maint | N | N | 270016024 | CETUXIMAB + RT |
| 270013909 | 270014438 | 1.64 | null | Curative (C) | 2018-06-23 | 2018-06-23 | DHAP | N | N | 270016024 | DHAP |
| 270013910 | 270014439 | null | 81.7 | Neo-adjuvant (N) | 2017-09-20 | 2017-10-14 | Bevacizumab + Oxaliplatin +MdG | 2 | Y | 270016033 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013911 | 270014439 | 1.65 | 64.8 | Curative (C) | 2017-04-12 | 2017-04-25 | CHOP R - 21 days | N | N | 270016033 | CHOP R |
| 270013912 | 270020082 | 1.8 | 45.8 | Curative (C) | 2014-11-11 | 2014-11-11 | DHAP | null | Y | 270016041 | DHAP |
| 270013913 | 270020082 | null | 66 | Palliative (P) | 2014-06-01 | 2014-06-08 | CISPLATIN + FLUOROURACIL | 02 | null | 270016041 | CISPLATIN + FLUOROURACIL |
| 270013914 | 270020082 | 1.77 | 65 | Adjuvant (A) | 2018-07-20 | 2018-08-18 | DHAP | N | N | 270016041 | DHAP |
| 270013915 | 270009488 | null | null | Curative (C) | 2016-03-11 | 2016-03-11 | Fluorouracil + Folinic Acid Weekly | null | null | 270016061 | FLUOROURACIL |
| 270013916 | 270009488 | null | 85.799 | null | 2013-09-25 | 2013-09-26 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016061 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013917 | 270009490 | 1.68 | 87.2 | Adjuvant (A) | null | 2013-07-30 | CAPECITABINE + RT | null | null | 270016073 | CAPECITABINE + RT |
| 270013918 | 270009491 | null | null | Curative (C) | 2016-10-06 | 2016-10-20 | CHOP R - 21 days | N | Y | 270016074 | CHOP R |
| 270013919 | 270009493 | 1.74 | 93.7 | Curative (C) | 2016-11-18 | 2017-08-23 | Shamash LBCMVD-56 | 02 | N | 270016081 | NOT MATCHED |
| 270013920 | 270009494 | null | 65.05 | Not known (9) | 2013-09-10 | 2014-04-24 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016089 | FLUOROURACIL |
| 270013921 | 270014442 | null | null | Palliative (P) | 2016-01-31 | 2016-01-31 | CAPECITABINE + IRINOTECAN | N | N | 270016090 | CAPECITABINE + IRINOTECAN |
| 270013922 | 270014442 | 1.52 | 63 | Palliative (P) | 2015-12-24 | 2015-12-24 | Trifluridine + Tipiracil | N | N | 270016090 | TRIFLURIDINE + TIPIRACIL |
| 270013923 | 270014442 | 1.84 | 69 | Palliative (P) | 2014-11-21 | 2014-11-24 | Cetuximab + Radiotherapy Maint | 02 | N | 270016090 | CETUXIMAB + RT |
| 270013924 | 270014442 | 1.63 | 74.4 | Curative (C) | 2016-05-24 | 2016-05-24 | CHLVPP | 02 | N | 270016090 | CHLVPP |
| 270013925 | 270009495 | 1.98 | null | Palliative (P) | 2017-09-17 | 2017-09-18 | Trifluridine + Tipiracil | N | Y | 270016109 | TRIFLURIDINE + TIPIRACIL |
| 270013926 | 270009496 | 1.85 | 85.1 | Palliative (P) | 2015-01-28 | 2015-03-27 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016115 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013927 | 270009497 | null | 64 | Palliative (P) | 2014-07-17 | 2014-07-26 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016118 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013928 | 270009498 | null | null | Curative (C) | 2017-03-06 | 2017-03-25 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016122 | FLUOROURACIL |
| 270013929 | 270009499 | 1.54 | 79.1 | Palliative (P) | 2016-02-22 | 2016-03-24 | Capecitabine (14 day) + Irinotecan | 1 | Y | 270016124 | CAPECITABINE + IRINOTECAN |
| 270013930 | 270014446 | 1.5 | 84.5 | Disease modification (D) | 2016-11-09 | 2016-11-13 | Capecitabine (14 day) + Irinotecan | 02 | N | 270016125 | CAPECITABINE + IRINOTECAN |
| 270013931 | 270009502 | 1.68 | 85 | Curative (C) | 2017-02-17 | 2017-02-24 | CHLVPP | null | null | 270016133 | CHLVPP |
| 270013932 | 270009504 | null | 72 | Adjuvant (A) | 2016-12-19 | 2016-12-19 | CAPECITABINE + IRINOTECAN | 02 | Y | 270016134 | CAPECITABINE + IRINOTECAN |
| 270013933 | 270014448 | 1.59 | 48.6 | Palliative (P) | 2015-02-04 | 2015-02-25 | Bevacizumab + Oxaliplatin +MdG | 02 | null | 270016135 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013934 | 270009506 | null | null | Curative (C) | 2015-07-02 | 2015-07-08 | DHAP | N | N | 270016137 | DHAP |
| 270013935 | 270014449 | 1.72 | 87.5 | Curative (C) | 2014-01-13 | 2014-02-24 | DHAP | N | N | 270016137 | DHAP |
| 270013936 | 270019223 | 1.74 | 106 | Curative (C) | 2015-01-26 | 2015-01-26 | Cetuximab + Radiotherapy Maint | N | Y | 270016149 | CETUXIMAB + RT |